Interaksi Tafenokuin

Tafenokuin (Krintafel, Arakoda), golongan antimalaria, memiliki 34 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 12 mayor, 19 moderat, 3 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (12)

  • Alogliptin dan metforminpenghambat DPP-4Mayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Dapagliflozin dan metforminpenghambat SGLT2Mayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • DofetilidantiaritmiaMayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Empagliflozin dan metforminpenghambat SGLT2Mayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Glipizid dan metforminsulfonilureaMayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Linagliptin dan metforminpenghambat DPP-4Mayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • MetforminbiguanidMayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Penicillamine should not be used in patients who are receiving concurrently gold therapy, antimalarial or cytotoxic drugs, oxyphenbutazone or phenylbutazone because these drugs are also associated with similar serious hematologic and renal adverse reactions. (label Penisilamin, Perhatian)

  • Pioglitazon dan metformintiazolidindionMayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Saksagliptin dan metforminpenghambat DPP-4Mayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

  • Sitagliptin dan metforminpenghambat DPP-4Mayor

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (label Tafenokuin, Interaksi obat)

Interaksi moderat (19)

  • Artikain dan epinefrinanestetik lokalModerat

    …ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase… (label Artikain dan epinefrin, Interaksi obat)

  • Bupivakainanestetik lokalModerat

    • Drugs Associated with Methemoglobinemia : Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (label Bupivakain, Interaksi obat)

  • Bupivakain dan epinefrinanestetik lokalModerat

    • Drugs Associated with Methemoglobinemia : Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (label Bupivakain dan epinefrin, Interaksi obat)

  • DarunavirantiretroviralModerat

    Antimalarial : artemether/lumefantrine ↓ artemether ↓ dihydroartemisinin ↑ lumefantrine ↔ darunavir The combination of PREZISTA/ritonavir and artemether/lumefantrine can be used without dose adjustments. (label Darunavir, Interaksi obat)

  • Darunavir dan kobisistatantiretroviralModerat

    Antimalarial: artemether/lumefantrine artemether: effect unknown lumefantrine: effect unknown Monitor for a potential decrease of antimalarial efficacy or potential QT prolongation. (label Darunavir dan kobisistat, Interaksi obat)

  • Droperidolantagonis dopaminModerat

    Possible pharmacodynamic interactions can occur between droperidol and potentially arrhythmogenic agents such as class I or III antiarrhythmics, antihistamines that prolong the QT interval, antimalarials, calcium channel blockers, neuroleptics that prolong the QT interval, and antidepressants. (label Droperidol, Interaksi obat)

  • EfavirenzantiretroviralModerat

    Antimalarials: Artemether/lumefantrine Atovaquone/ proguanil ↓ artemether * ↓ dihydroartemisinin * ↓ lumefantrine * ↓ atovaquone ↓ proguanil Consider alternatives to artemether/ lumefantrine because of the risk of QT interval prolongation. (label Efavirenz, Interaksi obat)

  • Antimalarials: Artemether/lumefantrine ↓ artemether ↓ dihydroartemisinin ↓ lumefantrine Consider alternatives to artemether/lumefantrine because of the risk of QT interval prolongation [see Warnings and Precautions (5.16) ] . (label Efavirenz, lamivudin, dan tenofovir, Interaksi obat)

  • EtravirinantiretroviralModerat

    Antimalarial : artemether/lumefantrine ↔ etravirine ↓ artemether ↓ dihydroartemisinin ↓ lumefantrine Caution is warranted when co-administering Etravirine and artemether/lumefantrine as it is unknown whether the decrease in exposure of artemether or its active metabolite, dihydroartemisinin, could result in decreased antimalarial efficacy. (label Etravirin, Interaksi obat)

  • Hidroksiklorokuinobat yang memperpanjang interval QTModerat

    Co-administration of PLAQUENIL with other antimalarials known to lower the seizure threshold (e.g., mefloquine) may increase the risk of seizures. (label Hidroksiklorokuin, Interaksi obat)

  • KlorokuinantimalariaModerat

    Patients infected with a resistant strain of plasmodia as shown by the fact that normally adequate doses have failed to prevent or cure clinical malaria or parasitemia should be treated with another form of antimalarial therapy. (label Klorokuin, Peringatan)

  • Kloroprokainanestetik lokalModerat

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (label Kloroprokain, Perhatian)

  • Lidokain dan epinefrinanestetik lokalModerat

    Drugs Associated with Methemoglobinemia: Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (label Lidokain dan epinefrin, Interaksi obat)

  • Lidokain dan prilokainanestetik lokalModerat

    …prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sufonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (label Lidokain dan prilokain, Interaksi obat)

  • MeflokuinantimalariaModerat

    Other Antimalarial Drugs Concomitant administration of mefloquine and other related antimalarial compounds (e.g., quinine, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions (see WARNINGS ). (label Meflokuin, Interaksi obat)

  • Mepivakainanestetik lokalModerat

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (label Mepivakain, Interaksi obat)

  • Prilokain dan epinefrinanestetik lokalModerat

    …ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine The administration… (label Prilokain dan epinefrin, Interaksi obat)

  • RifapentinantibiotikModerat

    …quinidine, tocainide Antibiotics Chloramphenicol, clarithromycin, dapsone, doxycycline; Fluoroquinolones (such as ciprofloxacin) Oral Anticoagulants Warfarin Anticonvulsants Phenytoin Antimalarials Quinine Azole Antifungals Fluconazole, itraconazole, ketoconazole Antipsychotics Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propranolol… (label Rifapentin, Interaksi obat)

  • Ropivakainanestetik lokalModerat

    …ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine NAROPIN should be… (label Ropivakain, Interaksi obat)

Penyebutan minor (3)

  • KuinidinantiaritmiaMinor

    Pediatric use In antimalarial trials, quinidine was as safe and effective in pediatric patients as in adults. (label Kuinidin, Perhatian)

  • KuininantimalariaMinor

    Other antimalarials (e.g., halofantrine, mefloquine). (label Kuinin, Interaksi obat)

  • PirimetaminantimalariaMinor

    Drug Interactions: Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. (label Pirimetamin, Interaksi obat)

Periksa Tafenokuin terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.